Unlocking the power of vaccines in the fight against AMR
To address this gap, the Microbiology Society convened a workshop bringing together 21 expert stakeholders across academia, industry, policy and the clinical and veterinary sectors. Chaired by Microbiology Society President Gordon Dougan, the discussions focussed on how vaccines can be better harnessed in the global response to AMR.
Key themes emerged from the workshop, including the urgent need to strengthen the evidence base for vaccine-mediated AMR reduction, removing policy and regulatory barriers that limit vaccine deployment in AMR strategies and creating incentives for public-private collaboration in vaccine development.
To realise the full potential of vaccines in tackling AMR, the workshop identified five critical areas for coordinated action:
- Integrating AMR into vaccine policies.
- Incentivising and supporting the inclusion of AMR reduction as a defined endpoint in clinical trials.
- Strengthening data and modelling.
- Fostering cross-sector partnerships.
- Clearly labelling AMR benefits.
The microbiology community has a critical role to play in advancing this agenda, particularly through research that builds the case for vaccines as a core tool in AMR prevention. As the global AMR crisis intensifies, unlocking the potential of vaccines must become a strategic priority.
Read the journal article summarising the workshop discussions.
Read the policy summary here:
This report is part of the Microbiology Society’s Knocking Out AMR project, an ambitious, bold and extensive scheme of work aiming to promote feasible and effective solutions to AMR. For any queries, please contact [email protected].
